GO:0016042 lipid catabolic process: Lipolysis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016042 lipid catabolic process describes the biochemical breakdown of lipids into free fatty acids and other products, a central energy-mobilizing pathway in cells.
• Cytosolic neutral lipases (PNPLA2/ATGL, LIPE/HSL) and lysosomal acid lipases (LIPA) are core enzymes that execute sequential lipid hydrolysis.
• Lipolysis is tightly regulated by hormones, phosphorylation cascades, and transcriptional programs that match energy supply to demand.
• Lipid catabolic process intersects with autophagy via lipophagy, linking lipid droplets to lysosomal degradation.
• Dysregulated lipid catabolism contributes to obesity, insulin resistance, hepatic steatosis, and cancer-associated metabolic reprogramming.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of lipid catabolic genes in metabolic and disease research.
Description
Lipids are essential structural and signaling molecules, but their controlled breakdown is equally critical for cellular energy homeostasis. The Gene Ontology term GO:0016042 lipid catabolic process encompasses the chemical reactions and pathways that degrade lipids, compounds soluble in organic solvents but sparingly in water, into simpler products such as free fatty acids, glycerol, and lysophospholipids. This process, often referred to as lipolysis, is fundamental to the mobilization of stored energy from lipid droplets in adipose tissue and other cell types. Researchers study lipid catabolic process because its dysregulation is linked to metabolic disorders, cancer, and developmental defects, and because it serves as a paradigm for understanding enzyme cascades, organelle interactions, and signal transduction. The pathway is executed by a series of lipases and accessory proteins that act on distinct lipid substrates in different cellular compartments, including the cytosol, lipid droplets, and lysosomes. Understanding the molecular players and regulatory mechanisms of lipid catabolic process is therefore essential for both basic cell biology and translational medicine.
lipid catabolic process At A Glance
| GO ID | GO:0016042 |
|---|---|
| GO term | lipid catabolic process |
| Ontology | biological_process |
| Synonym | lipid breakdown; lipid catabolism; lipid degradation; lipolysis; multicellular organismal lipid catabolic process; multicellular organism lipid catabolic process |
| Major function | Breakdown of lipids into free fatty acids, glycerol, and other products for energy production, membrane remodeling, and signaling |
| Key enzymes | PNPLA2/ATGL, LIPE/HSL, MGLL, LIPA, LPL, and others |
| Cellular locations | Cytosol, lipid droplets, lysosomes, endoplasmic reticulum, mitochondria |
| Regulatory inputs | Catecholamines, insulin, natriuretic peptides, phosphorylation cascades, transcription factors |
| Disease relevance | Obesity, insulin resistance, hepatic steatosis, cancer cachexia, lysosomal acid lipase deficiency |
What Is GO:0016042?
According to the Gene Ontology, GO:0016042 lipid catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. In practice, this includes the hydrolysis of triglycerides, phospholipids, and other lipids by lipases, as well as oxidative and non-oxidative degradation routes. The term is synonymous with lipid breakdown, lipid catabolism, lipid degradation, and lipolysis, and it is a biological process that occurs in multiple cellular contexts, from adipocyte lipolysis to lysosomal lipid hydrolysis.
Why Is lipid catabolic process Important in Cell Biology?
Lipid catabolic process is a cornerstone of energy metabolism and cellular homeostasis. It provides free fatty acids for mitochondrial beta-oxidation and ketogenesis during fasting, enables the remodeling of membrane lipids, and generates lipid signaling molecules that influence inflammation, insulin sensitivity, and gene expression. Its dysregulation is a hallmark of common metabolic diseases, including obesity and type 2 diabetes, and it plays a role in cancer cell survival and immune cell function. Moreover, the pathway is a target for therapeutic intervention, with lipase inhibitors and activators being explored for metabolic disorders. Studying lipid catabolic process therefore offers insights into fundamental cell biology and provides a basis for developing new treatments.
• Provides energy substrates during fasting and exercise through adipose tissue lipolysis.
• Regulates systemic lipid homeostasis and insulin sensitivity.
• Supports membrane remodeling and lipid signaling molecule production.
• Links to autophagy via lipophagy, a pathway for lipid droplet turnover.
• Implicated in obesity, type 2 diabetes, and non-alcoholic fatty liver disease.
• Plays a role in cancer metabolism and tumor microenvironment adaptation.
• Essential for normal development, including decidualization in early pregnancy.
• Target for pharmacological modulation of lipolysis in metabolic disease.
• Involved in immune cell function and inflammation resolution.
• Serves as a model for studying enzyme cascades and organelle crosstalk.
What Happens During lipid catabolic process?
Initiation of lipolysis at the lipid droplet
In simple terms: The first step in breaking down stored fat is the recognition and access of enzymes to the fat droplet.
Lipid catabolic process begins with the recruitment of lipases to the surface of lipid droplets. The rate-limiting enzyme adipose triglyceride lipase (PNPLA2/ATGL) catalyzes the initial hydrolysis of triacylglycerol to diacylglycerol and free fatty acid. This step is tightly regulated by accessory proteins such as CGI-58 (ABHD5) and perilipins, which control enzyme access to the droplet. Hormonal signals, including catecholamines and natriuretic peptides, trigger phosphorylation cascades that activate ATGL and promote its localization to lipid droplets.
Sequential hydrolysis by hormone-sensitive lipase and monoglyceride lipase
In simple terms: After the first cut, other enzymes continue to break down the remaining fat molecules step by step.
Following ATGL action, hormone-sensitive lipase (LIPE/HSL) hydrolyzes diacylglycerol to monoacylglycerol and free fatty acid. The final step is catalyzed by monoglyceride lipase (MGLL), which converts monoacylglycerol to glycerol and a free fatty acid. This sequential enzymatic cascade ensures efficient mobilization of fatty acids from stored triglycerides. The activity of HSL is regulated by phosphorylation by protein kinase A (PKA) in response to beta-adrenergic stimulation, while MGLL is constitutively active.
Lysosomal lipid catabolism and lipophagy
In simple terms: Cells can also digest fat inside lysosomes, either by direct enzyme action or by swallowing fat droplets.
In addition to cytosolic lipolysis, lipid catabolic process occurs in lysosomes through acid lipases such as LIPA (lysosomal acid lipase). This enzyme hydrolyzes cholesteryl esters and triglycerides delivered to lysosomes via endocytosis or autophagy. Lipophagy, a selective form of autophagy, targets lipid droplets for lysosomal degradation, providing an alternative route for lipid breakdown. This pathway is particularly important in hepatocytes and macrophages, and its dysfunction leads to lipid storage disorders.
Fatty acid oxidation and downstream metabolism
In simple terms: The fatty acids released from fat breakdown are then burned for energy or used to build other molecules.
The free fatty acids generated by lipolysis can be activated to fatty acyl-CoAs and transported into mitochondria for beta-oxidation, producing acetyl-CoA, NADH, and FADH2. In hepatocytes, acetyl-CoA can be converted to ketone bodies during fasting. Alternatively, fatty acids can serve as signaling molecules or substrates for membrane lipid synthesis. The glycerol backbone is phosphorylated and enters glycolysis or gluconeogenesis. This integration of lipid catabolic process with other metabolic pathways is essential for energy homeostasis.
Regulation of lipid catabolic process by hormones and nutrients
In simple terms: The body controls fat breakdown by sending hormonal signals that tell cells when to store or burn fat.
Lipid catabolic process is acutely regulated by hormones. Catecholamines, glucagon, and natriuretic peptides stimulate lipolysis through cAMP/PKA and cGMP/PKG signaling, leading to phosphorylation of perilipins, HSL, and ATGL. Insulin, in contrast, inhibits lipolysis by activating phosphodiesterase-3B and protein phosphatase-1, reducing cAMP levels and dephosphorylating lipases. Transcriptional regulation also plays a role; for example, the transcription factor IRF2BP2 has been shown to modulate adipocyte lipolysis. Additionally, GSK3β-regulated lipolysis is required for histone acetylation and decidualization in early pregnancy, linking lipid catabolism to epigenetic regulation.
Key Genes Involved in GO:0016042 lipid catabolic process
The following genes encode key enzymes, accessory proteins, and regulators of lipid catabolic process, and they are frequently studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PNPLA2 (ATGL) | Rate-limiting triglyceride lipase initiating lipolysis | Knockout causes lipid droplet accumulation; target for obesity and insulin resistance studies |
| LIPE (HSL) | Diacylglycerol and cholesteryl ester hydrolase | Phosphorylation-regulated; key for hormone-stimulated lipolysis |
| MGLL | Monoglyceride lipase completing triglyceride hydrolysis | Knockout leads to monoacylglycerol accumulation; involved in pain and inflammation |
| LIPA | Lysosomal acid lipase for cholesteryl esters and triglycerides | Deficiency causes Wolman disease and CESD; model for lysosomal storage disorders |
| ABHD5 (CGI-58) | Co-activator of ATGL | Mutations cause Chanarin-Dorfman syndrome; regulates lipid droplet access |
| PLIN1 | Perilipin 1, lipid droplet coat protein | Regulates lipase access; mutations linked to familial partial lipodystrophy |
| PLIN2 | Perilipin 2, lipid droplet stabilization | Modulates lipolysis and lipid storage in liver and muscle |
| PLIN5 | Perilipin 5, links lipid droplets to mitochondria | Promotes fatty acid oxidation; important in oxidative tissues |
| LPL | Lipoprotein lipase hydrolyzing plasma triglycerides | Deficiency causes hypertriglyceridemia; target for cardiovascular research |
| PNPLA3 | Patatin-like phospholipase domain-containing 3 | I148M variant associated with non-alcoholic fatty liver disease |
| FABP4 | Fatty acid binding protein 4 | Facilitates fatty acid transport; linked to insulin resistance |
| CIDEC | Cell death-inducing DFFA-like effector c | Regulates lipid droplet fusion and lipolysis; involved in lipodystrophy |
| IRF2BP2 | Transcriptional regulator of adipocyte lipolysis | Modulates lipolysis gene expression; potential therapeutic target |
| GSK3β | Glycogen synthase kinase 3 beta | Regulates lipolysis required for histone acetylation and decidualization |
| ATGL co-activators | Accessory proteins like CGI-58 | Modulate ATGL activity; targets for modulating lipolysis |
| Autophagy genes (ATG5, ATG7) | Lipophagy machinery | Required for lipid droplet turnover; link to autophagy |
| LAL (LIPA) regulators | Lysosomal lipid catabolism | Potential targets for lysosomal storage diseases |
| Adipose triglyceride lipase (ATGL) isoforms | Alternative splicing variants | May have distinct functions in different tissues |
How Is lipid catabolic process Regulated?
Lipid catabolic process is regulated at multiple levels. Acutely, hormones such as catecholamines and insulin control lipase activity through reversible phosphorylation. Beta-adrenergic signaling activates PKA, which phosphorylates HSL and perilipins, while insulin activates phosphodiesterase-3B to degrade cAMP and inhibit lipolysis. Natriuretic peptides act through cGMP/PKG to stimulate lipolysis. Transcriptional regulation includes the action of nuclear receptors and transcription factors such as IRF2BP2, which modulates adipocyte lipolysis gene expression. Additionally, GSK3β-regulated lipolysis is required for histone acetylation and decidualization in early pregnancy, indicating crosstalk between lipid catabolism and epigenetic regulation. Nutrient sensors such as AMPK and mTOR also influence lipolysis, integrating energy status with lipid mobilization.
lipid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPLA2 (ATGL) | Neutral lipid storage disease with myopathy; obesity | Knockout mice, patient-derived iPSCs, CRISPR KO in adipocytes |
| LIPE (HSL) | Familial partial lipodystrophy; insulin resistance | Knockout mice, CRISPR point mutations in HSL phosphorylation sites |
| LIPA | Lysosomal acid lipase deficiency (Wolman disease, CESD) | Knockout mice, patient fibroblasts, CRISPR knock-in of disease variants |
| PLIN1 | Familial partial lipodystrophy type 4 | CRISPR knock-in of mutant PLIN1 in adipocytes |
| PNPLA3 | Non-alcoholic fatty liver disease | CRISPR knock-in of I148M variant in hepatocytes |
Metabolic disorders: obesity and insulin resistance
Dysregulated lipid catabolic process is a hallmark of obesity and type 2 diabetes. Excessive lipolysis in adipose tissue increases circulating free fatty acids, which promote insulin resistance in muscle and liver. Conversely, impaired lipolysis can lead to lipid droplet accumulation and lipotoxicity. Genetic variants in PNPLA2, LIPE, and PLIN1 have been associated with altered lipolysis and metabolic disease risk. Targeting lipolysis pathways is therefore a promising therapeutic strategy for improving insulin sensitivity.
Cancer metabolism and cachexia
Cancer cells often reprogram lipid metabolism to support rapid proliferation. Increased lipolysis provides fatty acids for membrane synthesis and energy production, and it contributes to cancer cachexia, a wasting syndrome characterized by adipose tissue loss. In some cancers, upregulation of ATGL and HSL promotes tumor growth and survival. Inhibiting lipolysis has been explored as a therapeutic approach in preclinical models.
Lysosomal acid lipase deficiency and lipid storage diseases
Mutations in LIPA cause lysosomal acid lipase deficiency, which manifests as Wolman disease in infants and cholesteryl ester storage disease (CESD) in older patients. These disorders are characterized by accumulation of cholesteryl esters and triglycerides in lysosomes, leading to hepatomegaly, liver fibrosis, and cardiovascular complications. Understanding lysosomal lipid catabolism has led to enzyme replacement therapy for these conditions.
Reproductive and developmental roles
Lipid catabolic process is important for normal development. In early pregnancy, GSK3β-regulated lipolysis is required for histone acetylation and decidualization of the endometrium, a process essential for embryo implantation. This highlights the role of lipid catabolism beyond energy production, linking it to epigenetic regulation and reproductive success.
From lipid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATGL affect lipid droplet size and lipolysis? | PNPLA2 knockout cell line (e.g., adipocytes) |
| How do phosphorylation sites on HSL regulate lipolysis? | Point mutations (e.g., S563A, S565A) via CRISPR knock-in |
| What is the effect of a disease-associated LIPA mutation? | Knock-in of mutant LIPA in HepG2 or patient iPSCs |
| Can overexpression of PLIN5 enhance fatty acid oxidation? | Overexpression of PLIN5 in oxidative cell lines |
| What is the role of IRF2BP2 in adipocyte lipolysis? | Knockout and overexpression of IRF2BP2 in 3T3-L1 adipocytes |
| How does GSK3β regulate lipolysis in decidualization? | Knockout of GSK3β in endometrial stromal cells |
How to Study the lipid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glycerol release assay | Lipolysis rate | Assessing ATGL/HSL activity in adipocytes |
| BODIPY staining | Lipid droplet number and size | Visualizing lipid catabolism in cells |
| RNA-seq | Gene expression changes | Identifying transcriptional regulators of lipolysis |
| Phosphoproteomics | Phosphorylation of lipases | Mapping signaling cascades in lipolysis |
| CRISPR knockout screen | Genes affecting lipid catabolism | Discovery of novel regulators |
| Seahorse assay | Fatty acid oxidation rate | Measuring metabolic flux after genetic manipulation |
| Western blot | Protein levels and modifications | Validating knockout or overexpression |
| Immunofluorescence | Protein localization | Studying lipase recruitment to lipid droplets |
Lipolysis assays and lipid droplet imaging
Lipolysis can be measured by quantifying glycerol or free fatty acid release into the medium using colorimetric or fluorometric assays. Lipid droplet dynamics are visualized by staining with BODIPY 493/503 or Oil Red O and confocal microscopy. These methods allow researchers to assess the effects of genetic perturbations on lipid catabolic process.
Transcriptomics and proteomics
RNA sequencing (RNA-seq) can identify changes in expression of lipases and regulators upon genetic manipulation or treatment. Proteomics, including phosphoproteomics, reveals post-translational modifications of lipases and interacting proteins. These approaches provide a systems-level view of lipid catabolic process regulation.
Genetic screens and CRISPR libraries
CRISPR knockout libraries enable unbiased screening for genes that regulate lipid catabolism. For example, a genome-wide screen can identify novel regulators of lipid droplet accumulation or lipolysis. Such screens have uncovered genes like IRF2BP2 and GSK3β as modulators of lipolysis.
Metabolic flux analysis
Seahorse extracellular flux analysis and isotope tracing can measure fatty acid oxidation and metabolic flux through lipid catabolic pathways. These techniques quantify how genetic changes affect the utilization of fatty acids for energy production.
How CRISPR Can Be Used to Study GO:0016042 lipid catabolic process
Knockout
CRISPR knockout of genes such as PNPLA2, LIPE, or LIPA provides a direct way to test their requirement in lipid catabolic process. For example, PNPLA2 knockout cells accumulate lipid droplets and show reduced glycerol release, confirming its role as the rate-limiting lipase. Knockout models are also used to study compensatory mechanisms and to validate drug targets.
Point Mutation
CRISPR point mutations can mimic disease-associated variants or disrupt phosphorylation sites. For instance, introducing the PNPLA3 I148M variant or HSL phosphorylation site mutations (e.g., S563A) allows researchers to dissect signaling and function. These models are valuable for understanding how specific residues regulate lipolysis.
Knock-in
Knock-in of reporter tags or disease alleles enables tracking of lipases in live cells and studying mutant effects. Tagging endogenous ATGL with GFP or FLAG allows visualization of its recruitment to lipid droplets. Knock-in of LIPA mutations found in Wolman disease provides a model for testing enzyme replacement therapies.
Overexpression
Overexpression of lipases or regulators can enhance lipid catabolic process and reveal gain-of-function phenotypes. For example, overexpression of PLIN5 promotes fatty acid oxidation and reduces lipid droplet size. Overexpression of IRF2BP2 modulates lipolysis gene expression, providing insights into transcriptional control.
How EDITGENE Supports lipid catabolic process Research
Researchers studying lipid catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid mobilization, and how specific mutations affect enzyme function. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for lipid catabolic process research.
Frequently Asked Questions About lipid catabolic process
What is lipid catabolic process?
Lipid catabolic process (GO:0016042) is the set of biochemical reactions that break down lipids into simpler molecules such as free fatty acids and glycerol, often referred to as lipolysis.
What genes are involved in lipid catabolic process?
Key genes include PNPLA2 (ATGL), LIPE (HSL), MGLL, LIPA, ABHD5, PLIN1, and transcriptional regulators like IRF2BP2.
What is the difference between lipolysis and lipophagy?
Lipolysis is the enzymatic hydrolysis of lipids by cytosolic lipases, while lipophagy is the autophagic delivery of lipid droplets to lysosomes for degradation.
How is lipid catabolic process regulated?
It is regulated by hormones such as catecholamines and insulin, which control lipase phosphorylation, and by transcription factors like IRF2BP2.
Which diseases are associated with defective lipid catabolism?
Obesity, insulin resistance, non-alcoholic fatty liver disease, lysosomal acid lipase deficiency, and cancer cachexia are linked to altered lipid catabolism.
What is the role of ATGL in lipid catabolic process?
ATGL (PNPLA2) catalyzes the rate-limiting step of triglyceride hydrolysis, converting triglycerides to diacylglycerol and free fatty acid.
How can CRISPR be used to study lipid catabolic process?
CRISPR knockout, knock-in, and overexpression models allow researchers to test the function of specific genes and mutations in lipid catabolism.
What are common methods to measure lipolysis?
Glycerol release assays, free fatty acid quantification, and lipid droplet imaging with BODIPY are standard methods.
What is the link between lipid catabolism and pregnancy?
GSK3β-regulated lipolysis is required for histone acetylation and decidualization in early pregnancy.
What services does EDITGENE offer for lipid catabolism research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for lipid catabolism genes.
Conclusion
Lipid catabolic process (GO:0016042) is a fundamental biological pathway that governs energy mobilization, membrane remodeling, and signaling. Its dysregulation underlies prevalent metabolic diseases and contributes to cancer and developmental disorders. The pathway is orchestrated by a cascade of lipases and accessory proteins, tightly regulated by hormonal and transcriptional signals. CRISPR-based models have become indispensable for dissecting the causal roles of individual genes and mutations in lipid catabolism. EDITGENE offers a full spectrum of CRISPR services to support researchers in this field, from knockout to precise point mutations and library screening.
References
- 1. Grabner GF et al.. 2021. Lipolysis: cellular mechanisms for lipid mobilization from fat stores.. Nat Metab 3(11):1445-1465 PMID: 34799702
- 2. Cho CH et al.. 2023. Adipose tissue lipid metabolism: lipolysis.. Curr Opin Genet Dev 83:102114 PMID: 37738733
- 3. Yang A et al.. 2020. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics.. Biochem J 477(5):985-1008 PMID: 32168372
- 4. Zechner R et al.. 2012. FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.. Cell Metab 15(3):279-91 PMID: 22405066
- 5. Ahmadian M et al.. 2010. Lipolysis in adipocytes.. Int J Biochem Cell Biol 42(5):555-9 PMID: 20025992
- 6. Schott MB et al.. 2022. Lipophagy at a glance.. J Cell Sci 135(5) PMID: 35260889
- 7. Wang P et al.. 2026. GSK3β-Regulated Lipolysis is Required for Histone Acetylation and Decidualization in Early Pregnancy.. Adv Sci (Weinh) 13(5):e14291 PMID: 41208306
- 8. Chen Y et al.. 2025. Transcriptional regulation of adipocyte lipolysis by IRF2BP2.. Sci Adv 11(1):eads5963 PMID: 39752494
